Minutia
PrivateLast Round
Grant
Jul 31, 2024
Total Funding Raised
$3.23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Minutia operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Grant round in July 2024.
Minutia is a biotechnology company that develops insulin-producing cell transplants combined with nanosensors to treat type 1 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sensors, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minutia Comparables
Compare Minutia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seraxis | 88% | |
| NewcelX Ltd. | 81% | |
| iTolerance, Inc. | 81% |
For institutional investors. Book with your work email.
Minutia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 31, 2024 | ||||
| Grant | Apr 12, 2024 | ||||
| Grant | Sep 18, 2023 | ||||
| Grant | May 22, 2023 | ||||
| Grant | Sep 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Minutia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| California Institute for Regenerative Medicine | Grant |
| JDRF | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 44% MoM, reaching 5.7K.
- Apr 17, 2026
Monthly visitors increased 33% MoM, reaching 4.6K.
For institutional investors. Book with your work email.
Minutia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Minutia's valuation, stock price, and market status.
Is Minutia a public or private company?
Minutia is a private company.
What is the current stock price of Minutia?
Minutia is a private company, so its shares have no public market price. Caplight tracks Minutia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Minutia worth (valuation)?
Valuation information for Minutia is not publicly available.
Can I buy Minutia stock?
Minutia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Minutia's last funding round?
Minutia's most recent funding round was Grant on July 31, 2024.
Who are the main investors in Minutia?
Key investors in Minutia include National Institute of Diabetes and Digestive and Kidney Diseases, California Institute for Regenerative Medicine, JDRF, National Institutes of Health (NIH).
Will Minutia IPO soon?
No public IPO plans have been announced for Minutia.
How can I track Minutia secondary market activity?
Caplight tracks bids, offers, and trades in Minutia's shares on secondary markets.